Articles > Newspapers > U.S. Newspapers, Major Markets > Knight Ridder/Tribune Business News news wires > October-December 2004 > Saturday, December 18

Article: Pfizer issues alert for users of Celebrex pain reliever.

Article from:
Knight Ridder/Tribune Business News
Article date:
December 18, 2004
Copyright

By Sherry Jacobson, The Dallas Morning News Knight Ridder/Tribune Business News

Dec. 18--People taking large doses of the popular pain reliever Celebrex are more than twice as likely to suffer a heart attack than those not taking it, the drug's maker said Friday.

Pfizer Inc. issued an alert for users of the drug but stopped short of removing it from the market. Nearly three months ago, Merck & Co. withdrew Vioxx, another popular pain reliever, after a study found a similar increased risk of heart attacks and other serious side effects.

Ironically, Vioxx users were told they could switch to Celebrex, which was considered a safer version ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Makers of Pain Pills Celebrex, Vioxx Seek Cure for ...
Knight Ridder/Tribune Business News;  October 28, 2001 ;     700+ words ... ... traditional painkillers. But Celebrex and Vioxx are losing their superstar aura ... comparable stomach benefits of Celebrex and Vioxx over older medicines. The new ... products' continued growth. Celebrex and Vioxx are wildly popular among physicians ...

Article: Study: Celebrex Appears Safer Than Vioxx
AP Online;  December 7, 2004 ;     700+ words ... ... inhibitors may carry similar dangers. "Vioxx and Celebrex look different. Relative to Celebrex, Vioxx had about a threefold greater risk of ... problems. Studies done five years ago _ when Celebrex and Vioxx were approved _ suggest the same mechanism ...

Article: Study shows Celebrex appears to be safer than ...
Immunotherapy Weekly;  December 29, 2004 ;     700+ words ... ... inhibitors may carry similar dangers. "Vioxx and Celebrex look different. Relative to Celebrex, Vioxx had about a threefold greater risk of ... problems. Studies done 5 years ago, when Celebrex and Vioxx were approved, suggest the same mechanism ...

Article: Study: Celebrex appears safer than Vioxx; Heart ...
Telegraph - Herald (Dubuque);  December 8, 2004 ;     700+ words ... ... inhibitors might carry similar dangers. "Vioxx and Celebrex look different. Relative to Celebrex, Vioxx had about a threefold greater risk of ... problems. Studies done five years ago - when Celebrex and Vioxx were approved - suggest the same mechanism ...

Article: Heart Risk From Celebrex, Vioxx?; 'Super Aspirin' ...
The Washington Post;  August 22, 2001 ;     700+ words ... ... popular painkillers Celebrex and Vioxx may slightly increase ... assigned to get either Celebrex or one of two NSAIDs ... groups. In the Vioxx trial, however ... risk factors in the Celebrex trial and found ... Merck, which makes Vioxx, said that company ...

Article: CELEBREX AND VIOXX: ARE THEY SAFER THAN THE OLDER ...
HealthFacts;  September 1, 2001 ;     700+ words ... ... anti-inflammatory drugs, Celebrex and Vioxx, came on the market two and ... heart-related risks linked to Celebrex and Vioxx? A new analysis of all clinical ... appear safer than it really is. Celebrex and Vioxx belong to a relatively new class ...

Article: Journal: Drug Sales Based on 'Seriously Biased' Data; ...
The Washington Post;  June 4, 2002 ;     700+ words ...Vioxx and Celebrex are supposed to relieve pain, but ... 2. Express Scripts asserts that Vioxx, Celebrex and Bextra (another COX-2 drug ... to Express Scripts. The makers of Vioxx and Celebrex assert that their drugs have a distinct ...

Article: Celebrex and Vioxx: Why two cox-2 inhibitors for ...
The Journal Record;  September 29, 1999 ;     700+ words ... ... lead: Merck, with Vioxx, and Monsanto (marketed by Pfizer) with Celebrex. These pharmaceutical ... drugs). Now that both Vioxx and Celebrex are on the market ... recent concern with Celebrex. Vioxx has a single dose form ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives